Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxercalciferol in Kidney Transplant Recipients
NCT00889629Phase 4Completed
- Start
- Nov 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of doxercalciferol in secondary hyperparathyroidism (SHPT) (2 arms). Primary endpoint: Proportion of patients with iPTH value of 100 pg/ml or lower at 6 months. Started Nov 2008; status: completed.
02
Drugs
doxercalciferol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00889629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889629.